Antibe amends follow-on

On May 26, pain and inflammation company Antibe Therapeutics Inc. (TSX-V:ATE; OTCQX:ATBPF) amended its follow-on to raise up to C$5 million ($3.7 million), saying it would offer each unit at C$0.10. Bloom, Dominick and Echelon Wealth are agents for the financing...